 |
|
|
| |
Universal Access to Direct Acting Antiviral Treatment and High Engagement in Care Results in a Major Drop in Hepatitis C Viremia in People Who Inject DrugsResults from TraPHepCin Iceland (Treatment as Prevention) - AASLD-EASL HCV Special Conference Miami 2/1/19
|
| |
| |
Reported by Jules Levin
2019 AASLD/EASL HCV Special Conference 01-02 February 2019, Miami, FL
ValgerdurRunarsdottir1, ThorarinnTyrfingsson1, RagnheidurH. Fridriksdottir2, Ingunn Hansdottir1,3, OttarM. Bergmann2, Einar S. Bjornsson2,4, Birgir Johannsson5, BryndisSigurdardottir5, Arthur Love4,6, Thorvardur J. Love4,7, Gudrun Sigmundsdottir8, Ubaldo Benitez Hernandez7, Maria Heimisdottir4,9, Sigurdur Olafsson2,4,Magnus Gottfredsson4,5,7and the TraPHepCworking group.
1SAA National Center for Addiction Medicine -Reykjavik Iceland,2Department of Gastroenterology and Hepatology, LandspitaliUniversity Hospital, 3Faculty of Psychology, School of Health Sciences, University of Iceland, 4Faculty of Medicine, School of Health Sciences, University of Iceland5Department of Infectious Diseases, LandspitaliUniversity Hospital, 6Department of Virology, LandspitaliUniversity Hospital, 7Department of Science, LandspitaliUniversity Hospital
|
| |
|
|
|
|
|
